Patel Chirag K. has filed 25 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 544663 shares of Amneal Pharmaceuticals, Inc. ($AMRX) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Performance-Based Restricted Stock Units | 544663 | $0.00 | 544,663.0000 | 324,754,000 | 9999.99% | 0.17% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Class A Common Stock | 59931 | $0.00 | 22,187,331.0000 | 324,754,000 | 0.27% | 0.02% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | F | Class A Common Stock | 15616 | $13.31 | 22,171,715.0000 | 324,754,000 | 0.07% | 0.00% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Class A Common Stock | 733944 | $0.00 | 22,905,659.0000 | 324,754,000 | 3.31% | 0.23% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | F | Class A Common Stock | 297537 | $13.31 | 22,608,122.0000 | 324,754,000 | 1.30% | 0.09% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Class A Common Stock | 92593 | $0.00 | 22,700,715.0000 | 324,754,000 | 0.41% | 0.03% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | F | Class A Common Stock | 37825 | $13.30 | 22,662,890.0000 | 324,754,000 | 0.17% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Performance-Based Restricted Stock Units | 733944 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.23% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Restricted Stock Units | 92593 | $0.00 | 185,185.0000 | 324,754,000 | 33.33% | 0.03% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Restricted Stock Units | 59931 | $0.00 | 179,795.0000 | 324,754,000 | 25.00% | 0.02% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Performance-Based Restricted Stock Units | 354031 | $0.00 | 354,031.0000 | 324,754,000 | 9999.99% | 0.11% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Restricted Stock Units | 190632 | $0.00 | 190,632.0000 | 324,754,000 | 9999.99% | 0.06% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Class A Common Stock | 579710 | $0.00 | 22,361,696.0000 | 308,978,000 | 2.66% | 0.19% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | F | Class A Common Stock | 279527 | $8.76 | 22,082,169.0000 | 308,978,000 | 1.25% | 0.09% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Class A Common Stock | 92592 | $0.00 | 22,174,761.0000 | 308,978,000 | 0.42% | 0.03% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | F | Class A Common Stock | 47361 | $8.84 | 22,127,400.0000 | 308,978,000 | 0.21% | 0.02% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Performance-Based Restricted Stock Units | 579710 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.19% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Performance-Based Restricted Stock Units | 890410 | $0.00 | 890,410.0000 | 308,978,000 | 9999.99% | 0.29% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Restricted Stock Units | 239726 | $0.00 | 239,726.0000 | 308,978,000 | 9999.99% | 0.08% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | M | Restricted Stock Units | 92592 | $0.00 | 277,778.0000 | 308,978,000 | 25.00% | 0.03% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Performance-Based Restricted Stock Units | 1333334 | $0.00 | 1,333,334.0000 | 176,136,000 | 9999.99% | 0.76% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Restricted Stock Units | 370370 | $0.00 | 370,370.0000 | 176,136,000 | 9999.99% | 0.21% |
| Nov. 7, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | J | Class B Common Stock and Common Units | 21269420 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 14.09% |
| Nov. 7, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | J | Class A Common Stock | 21269420 | $0.00 | 21,781,986.0000 | 150,944,000 | 4149.60% | 14.09% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Patel Chirag K. | President & Co-CEO | A | Performance-Based Restricted Stock Units | 733944 | $0.00 | 733,944.0000 | 150,944,000 | 9999.99% | 0.49% |